 Robert Mcduffie
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Infectious | 13 | 2004 | 261 | 1.050 |
Why?
| | Escherichia coli Infections | 9 | 2002 | 128 | 0.870 |
Why?
| | Fetal Diseases | 4 | 2002 | 193 | 0.560 |
Why?
| | Streptococcus agalactiae | 5 | 1999 | 86 | 0.490 |
Why?
| | Pregnancy | 34 | 2014 | 5185 | 0.480 |
Why?
| | Streptococcal Infections | 5 | 1999 | 139 | 0.470 |
Why?
| | Amniotic Fluid | 7 | 2002 | 75 | 0.470 |
Why?
| | Sulbactam | 5 | 2002 | 6 | 0.420 |
Why?
| | Ampicillin | 5 | 2002 | 13 | 0.420 |
Why?
| | Prenatal Care | 4 | 2004 | 220 | 0.400 |
Why?
| | Pregnancy Outcome | 5 | 2014 | 340 | 0.380 |
Why?
| | Rabbits | 14 | 2004 | 816 | 0.380 |
Why?
| | Uterine Diseases | 3 | 2002 | 15 | 0.370 |
Why?
| | Postpartum Hemorrhage | 1 | 2007 | 9 | 0.350 |
Why?
| | Balloon Occlusion | 1 | 2007 | 16 | 0.350 |
Why?
| | Office Visits | 2 | 1997 | 95 | 0.320 |
Why?
| | Catheterization | 1 | 2007 | 181 | 0.320 |
Why?
| | Pregnancy in Diabetics | 2 | 2012 | 88 | 0.320 |
Why?
| | Diabetes, Gestational | 4 | 2012 | 263 | 0.310 |
Why?
| | alpha-Fetoproteins | 2 | 1996 | 39 | 0.300 |
Why?
| | Bacteremia | 3 | 1999 | 164 | 0.280 |
Why?
| | Gardnerella vaginalis | 1 | 2002 | 4 | 0.260 |
Why?
| | Fetal Membranes, Premature Rupture | 2 | 1993 | 38 | 0.250 |
Why?
| | Pre-Eclampsia | 2 | 2001 | 163 | 0.230 |
Why?
| | Sialoglycoproteins | 2 | 2001 | 185 | 0.220 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2001 | 76 | 0.220 |
Why?
| | Bacterial Infections | 1 | 2002 | 217 | 0.220 |
Why?
| | Weight Gain | 2 | 2014 | 487 | 0.200 |
Why?
| | Receptors, Interleukin-1 | 1 | 2001 | 249 | 0.200 |
Why?
| | Breast Diseases | 1 | 1999 | 18 | 0.200 |
Why?
| | Meconium | 1 | 1999 | 8 | 0.200 |
Why?
| | Pregnancy, Multiple | 1 | 1999 | 20 | 0.200 |
Why?
| | Hepatitis A | 1 | 1999 | 26 | 0.200 |
Why?
| | Escherichia coli | 3 | 2002 | 813 | 0.190 |
Why?
| | Puerperal Infection | 1 | 1998 | 4 | 0.190 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 1999 | 54 | 0.190 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 81 | 0.190 |
Why?
| | Pregnancy Complications | 2 | 2014 | 484 | 0.190 |
Why?
| | Peritonitis | 1 | 1999 | 77 | 0.190 |
Why?
| | Levofloxacin | 1 | 1998 | 26 | 0.190 |
Why?
| | Ofloxacin | 1 | 1998 | 27 | 0.190 |
Why?
| | Breast Feeding | 2 | 2012 | 347 | 0.180 |
Why?
| | Uterus | 6 | 2007 | 205 | 0.180 |
Why?
| | Adiposity | 3 | 2013 | 483 | 0.180 |
Why?
| | Female | 36 | 2014 | 62627 | 0.180 |
Why?
| | Trisomy | 2 | 1996 | 61 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2002 | 1244 | 0.170 |
Why?
| | Fetal Death | 3 | 2002 | 49 | 0.170 |
Why?
| | Genital Diseases, Female | 1 | 1996 | 26 | 0.160 |
Why?
| | Estriol | 1 | 1996 | 6 | 0.160 |
Why?
| | Health Services | 1 | 1997 | 100 | 0.160 |
Why?
| | Chorionic Gonadotropin | 1 | 1996 | 79 | 0.150 |
Why?
| | Ultrasonography, Prenatal | 2 | 1996 | 262 | 0.150 |
Why?
| | Anti-Infective Agents | 1 | 1998 | 227 | 0.150 |
Why?
| | Pregnancy Trimester, Second | 2 | 1994 | 78 | 0.150 |
Why?
| | Aztreonam | 1 | 1995 | 7 | 0.150 |
Why?
| | Gentamicins | 1 | 1995 | 35 | 0.150 |
Why?
| | Amnion | 1 | 1995 | 28 | 0.150 |
Why?
| | Placenta Accreta | 1 | 1994 | 5 | 0.140 |
Why?
| | Hemoperitoneum | 1 | 1994 | 15 | 0.140 |
Why?
| | Prenatal Diagnosis | 1 | 1996 | 177 | 0.140 |
Why?
| | Drug Therapy, Combination | 5 | 2002 | 999 | 0.140 |
Why?
| | Obesity | 3 | 2014 | 2602 | 0.140 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 1994 | 48 | 0.140 |
Why?
| | Ampicillin Resistance | 1 | 1993 | 1 | 0.140 |
Why?
| | Amoxicillin | 1 | 1993 | 11 | 0.140 |
Why?
| | Subcutaneous Fat | 1 | 2014 | 84 | 0.130 |
Why?
| | Klebsiella Infections | 1 | 1993 | 24 | 0.130 |
Why?
| | Klebsiella pneumoniae | 1 | 1993 | 34 | 0.130 |
Why?
| | Abortion, Veterinary | 1 | 1992 | 1 | 0.130 |
Why?
| | Fetus | 4 | 2002 | 674 | 0.130 |
Why?
| | Infant, Newborn | 10 | 2012 | 5017 | 0.130 |
Why?
| | Adolescent Development | 1 | 2013 | 97 | 0.120 |
Why?
| | Hyperinsulinism | 1 | 2013 | 111 | 0.120 |
Why?
| | Hypertension | 1 | 2001 | 1166 | 0.120 |
Why?
| | Abnormalities, Multiple | 1 | 1994 | 173 | 0.120 |
Why?
| | Cervix Uteri | 1 | 1992 | 51 | 0.120 |
Why?
| | Adiponectin | 1 | 2013 | 208 | 0.120 |
Why?
| | Child of Impaired Parents | 1 | 2012 | 49 | 0.120 |
Why?
| | Down Syndrome | 1 | 1996 | 291 | 0.120 |
Why?
| | Thiazolidinediones | 1 | 2013 | 161 | 0.120 |
Why?
| | Cesarean Section | 2 | 2007 | 147 | 0.110 |
Why?
| | Down-Regulation | 1 | 2013 | 681 | 0.110 |
Why?
| | Insulin Resistance | 2 | 2013 | 1140 | 0.110 |
Why?
| | Body Mass Index | 3 | 2014 | 2076 | 0.100 |
Why?
| | Islets of Langerhans | 1 | 1996 | 709 | 0.100 |
Why?
| | Physical Examination | 1 | 1992 | 245 | 0.100 |
Why?
| | Adult | 13 | 2014 | 31793 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 1999 | 1430 | 0.090 |
Why?
| | Fetal Growth Retardation | 1 | 2013 | 431 | 0.090 |
Why?
| | Child Development | 1 | 2013 | 469 | 0.090 |
Why?
| | Disease Models, Animal | 6 | 2004 | 3892 | 0.090 |
Why?
| | Glycated Hemoglobin A | 1 | 2013 | 822 | 0.090 |
Why?
| | Humans | 25 | 2014 | 112255 | 0.090 |
Why?
| | Interleukin-1 | 1 | 1992 | 1045 | 0.090 |
Why?
| | Animals | 14 | 2004 | 35194 | 0.090 |
Why?
| | Maternal Age | 2 | 2005 | 121 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2004 | 3262 | 0.090 |
Why?
| | Hysterectomy | 1 | 2007 | 104 | 0.080 |
Why?
| | Embolization, Therapeutic | 1 | 2007 | 95 | 0.080 |
Why?
| | Mass Screening | 4 | 2005 | 1038 | 0.080 |
Why?
| | Colorado | 6 | 2013 | 4552 | 0.080 |
Why?
| | Health Maintenance Organizations | 2 | 1996 | 106 | 0.080 |
Why?
| | Arteries | 1 | 2007 | 231 | 0.080 |
Why?
| | Bacteroidaceae Infections | 1 | 2004 | 5 | 0.070 |
Why?
| | Prevotella | 1 | 2004 | 13 | 0.070 |
Why?
| | Confidence Intervals | 2 | 2004 | 347 | 0.070 |
Why?
| | Obstetric Labor, Premature | 1 | 2004 | 44 | 0.070 |
Why?
| | Waist Circumference | 2 | 2014 | 131 | 0.070 |
Why?
| | Delivery, Obstetric | 1 | 2004 | 121 | 0.070 |
Why?
| | Random Allocation | 2 | 2001 | 402 | 0.060 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2001 | 287 | 0.060 |
Why?
| | Time Factors | 5 | 2013 | 7054 | 0.060 |
Why?
| | Osmolar Concentration | 1 | 2002 | 230 | 0.060 |
Why?
| | Cohort Studies | 5 | 2013 | 4937 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2013 | 1695 | 0.060 |
Why?
| | Adolescent | 5 | 2013 | 18579 | 0.050 |
Why?
| | Dinoprostone | 1 | 2001 | 189 | 0.050 |
Why?
| | Risk Factors | 5 | 2004 | 8979 | 0.050 |
Why?
| | Risk | 2 | 2013 | 944 | 0.050 |
Why?
| | Tetanus Toxoid | 1 | 1999 | 42 | 0.050 |
Why?
| | Body Temperature | 1 | 2001 | 280 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2001 | 393 | 0.050 |
Why?
| | Chi-Square Distribution | 1 | 2001 | 572 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2013 | 2001 | 0.050 |
Why?
| | Polysaccharides, Bacterial | 1 | 1999 | 65 | 0.050 |
Why?
| | Reference Values | 1 | 2001 | 876 | 0.050 |
Why?
| | Ascites | 1 | 1999 | 36 | 0.050 |
Why?
| | Bacterial Vaccines | 1 | 1999 | 65 | 0.050 |
Why?
| | Chronic Disease | 2 | 2002 | 1666 | 0.050 |
Why?
| | Urban Population | 1 | 2001 | 419 | 0.050 |
Why?
| | Fatal Outcome | 1 | 1999 | 314 | 0.050 |
Why?
| | Autoimmunity | 1 | 2004 | 771 | 0.050 |
Why?
| | Odds Ratio | 1 | 2001 | 1061 | 0.040 |
Why?
| | Fetal Movement | 1 | 1997 | 7 | 0.040 |
Why?
| | Animals, Newborn | 2 | 1999 | 868 | 0.040 |
Why?
| | Fetal Monitoring | 1 | 1997 | 26 | 0.040 |
Why?
| | Twins | 1 | 1999 | 289 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2002 | 825 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2013 | 2878 | 0.040 |
Why?
| | Child | 5 | 2014 | 17358 | 0.040 |
Why?
| | Incidence | 2 | 2001 | 2453 | 0.040 |
Why?
| | Amniocentesis | 1 | 1996 | 25 | 0.040 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 1996 | 49 | 0.040 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 1996 | 22 | 0.040 |
Why?
| | Oropharynx | 1 | 1996 | 40 | 0.040 |
Why?
| | Karyotyping | 1 | 1996 | 130 | 0.040 |
Why?
| | Histocompatibility Testing | 1 | 1996 | 134 | 0.040 |
Why?
| | Comorbidity | 1 | 2001 | 1598 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 1996 | 164 | 0.040 |
Why?
| | Insulin Antibodies | 1 | 1996 | 106 | 0.040 |
Why?
| | Administration, Oral | 1 | 1998 | 800 | 0.040 |
Why?
| | Genetic Counseling | 1 | 1996 | 66 | 0.040 |
Why?
| | Chromosome Aberrations | 1 | 1996 | 145 | 0.040 |
Why?
| | Acoustic Stimulation | 1 | 1997 | 367 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2001 | 2021 | 0.040 |
Why?
| | Logistic Models | 1 | 2001 | 2049 | 0.040 |
Why?
| | HLA-DQ Antigens | 1 | 1996 | 189 | 0.040 |
Why?
| | Genotype | 2 | 2004 | 2070 | 0.040 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1996 | 143 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 1996 | 133 | 0.040 |
Why?
| | HLA-DR Antigens | 1 | 1996 | 236 | 0.040 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2011 | 458 | 0.040 |
Why?
| | HLA Antigens | 1 | 1996 | 240 | 0.040 |
Why?
| | Dandy-Walker Syndrome | 1 | 1994 | 6 | 0.040 |
Why?
| | Endometrium | 1 | 1995 | 73 | 0.030 |
Why?
| | Ultrasonography | 1 | 1999 | 764 | 0.030 |
Why?
| | Antithrombin III Deficiency | 1 | 1993 | 3 | 0.030 |
Why?
| | Indomethacin | 1 | 1993 | 86 | 0.030 |
Why?
| | Pregnancy Complications, Hematologic | 1 | 1993 | 18 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 1993 | 38 | 0.030 |
Why?
| | Abdominal Fat | 1 | 2013 | 44 | 0.030 |
Why?
| | Male | 8 | 2014 | 60721 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2014 | 235 | 0.030 |
Why?
| | Subclavian Vein | 1 | 1993 | 27 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2001 | 3353 | 0.030 |
Why?
| | Sulfonylurea Compounds | 1 | 2013 | 38 | 0.030 |
Why?
| | Alleles | 1 | 1996 | 905 | 0.030 |
Why?
| | Fetal Blood | 3 | 2004 | 267 | 0.030 |
Why?
| | Autoimmune Diseases | 1 | 1996 | 432 | 0.030 |
Why?
| | Infant, Premature | 1 | 1996 | 448 | 0.030 |
Why?
| | Warfarin | 1 | 1993 | 138 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2013 | 11118 | 0.030 |
Why?
| | Pregnancy Trimester, Third | 1 | 1992 | 81 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 1996 | 600 | 0.030 |
Why?
| | Blood Glucose | 1 | 2001 | 1908 | 0.030 |
Why?
| | Cytokines | 1 | 2000 | 1974 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 1991 | 127 | 0.030 |
Why?
| | Prospective Studies | 3 | 2014 | 6168 | 0.030 |
Why?
| | Infant | 2 | 2012 | 8024 | 0.030 |
Why?
| | Obstetrics | 1 | 1992 | 139 | 0.030 |
Why?
| | Thrombosis | 1 | 1993 | 264 | 0.030 |
Why?
| | Brain | 1 | 2002 | 2664 | 0.030 |
Why?
| | Progesterone | 1 | 1991 | 252 | 0.030 |
Why?
| | Anti-Bacterial Agents | 2 | 1996 | 1305 | 0.030 |
Why?
| | Metformin | 1 | 2013 | 281 | 0.020 |
Why?
| | Autoantibodies | 1 | 1996 | 1208 | 0.020 |
Why?
| | Biomarkers | 2 | 1996 | 3465 | 0.020 |
Why?
| | Algorithms | 1 | 1994 | 1548 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2674 | 0.020 |
Why?
| | Birth Order | 1 | 2004 | 12 | 0.020 |
Why?
| | Placenta | 2 | 2000 | 554 | 0.020 |
Why?
| | African Americans | 1 | 2010 | 1096 | 0.020 |
Why?
| | Regression Analysis | 1 | 2005 | 1136 | 0.010 |
Why?
| | Treatment Failure | 1 | 2002 | 327 | 0.010 |
Why?
| | Opsonin Proteins | 1 | 1999 | 26 | 0.010 |
Why?
| | Peritoneum | 1 | 1999 | 38 | 0.010 |
Why?
| | Vaccines, Conjugate | 1 | 1999 | 51 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 191 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 1999 | 136 | 0.010 |
Why?
| | Palpation | 1 | 1997 | 16 | 0.010 |
Why?
| | Acute Disease | 1 | 2000 | 997 | 0.010 |
Why?
| | Child, Preschool | 1 | 2012 | 9655 | 0.010 |
Why?
| | Gestational Age | 1 | 1999 | 765 | 0.010 |
Why?
| | Quality Control | 1 | 1996 | 176 | 0.010 |
Why?
| | NF-kappa B | 1 | 2000 | 715 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1999 | 787 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 597 | 0.010 |
Why?
| | Uterine Cervical Diseases | 1 | 1993 | 5 | 0.010 |
Why?
| | Premedication | 1 | 1993 | 39 | 0.010 |
Why?
| | Contraindications | 1 | 1993 | 97 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 1099 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2004 | 4550 | 0.010 |
Why?
| | Feasibility Studies | 1 | 1994 | 727 | 0.010 |
Why?
| | Patient Compliance | 1 | 1996 | 604 | 0.010 |
Why?
| | Inflammation | 1 | 2002 | 2427 | 0.010 |
Why?
| | Lung | 1 | 2000 | 3587 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1996 | 4888 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1993 | 8944 | 0.000 |
Why?
|
|
Mcduffie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|